Skip to main content
. Author manuscript; available in PMC: 2021 Apr 6.
Published in final edited form as: Heart. 2018 May 2;104(22):1859–1863. doi: 10.1136/heartjnl-2017-312934

Figure 1.

Figure 1.

Forest plot detailing reporting Odds-Ratio (ROR) of suspected adverse drug reactions (ADR) related to acquired long QT, Torsade-de-Pointes, or ventricular arrhythmias between selective estrogen receptor modulators (SERMs) and aromatase inhibitors (AIs) collected from the European database of suspected ADR reports accessed in 08/2017.